Imperial College London

DrMarkBirrell

Faculty of MedicineNational Heart & Lung Institute

Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 8578m.birrell

 
 
//

Location

 

103Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Nilsson:2022:10.2147/DDDT.S354291,
author = {Nilsson, M and Rhedin, M and Hendrickx, R and Berglund, S and Piras, A and Blomgran, P and Cavallin, A and Collins, M and Dahl, G and Dekkak, B and Ericsson, T and Hagberg, N and Holmberg, AA and Leffler, A and Lundqvist, AJ and Markou, T and Pinkerton, J and Ronnblom, L and Siu, S and Taylor, V and Wennberg, T and Zervas, D and Laurence, ADJ and Mitra, S and Belvisi, MG and Birrell, M and Borde, A},
doi = {10.2147/DDDT.S354291},
journal = {DRUG DESIGN DEVELOPMENT AND THERAPY},
pages = {2901--2917},
title = {Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma},
url = {http://dx.doi.org/10.2147/DDDT.S354291},
volume = {16},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Nilsson,M
AU - Rhedin,M
AU - Hendrickx,R
AU - Berglund,S
AU - Piras,A
AU - Blomgran,P
AU - Cavallin,A
AU - Collins,M
AU - Dahl,G
AU - Dekkak,B
AU - Ericsson,T
AU - Hagberg,N
AU - Holmberg,AA
AU - Leffler,A
AU - Lundqvist,AJ
AU - Markou,T
AU - Pinkerton,J
AU - Ronnblom,L
AU - Siu,S
AU - Taylor,V
AU - Wennberg,T
AU - Zervas,D
AU - Laurence,ADJ
AU - Mitra,S
AU - Belvisi,MG
AU - Birrell,M
AU - Borde,A
DO - 10.2147/DDDT.S354291
EP - 2917
PY - 2022///
SN - 1177-8881
SP - 2901
TI - Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma
T2 - DRUG DESIGN DEVELOPMENT AND THERAPY
UR - http://dx.doi.org/10.2147/DDDT.S354291
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000874754800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 16
ER -